Is the Pepsico Turnaround Story Finally Worth Buying?
Briefly

Is the Pepsico Turnaround Story Finally Worth Buying?
"PepsiCo's top line grew, but the mix revealed pressure. Organic revenue rose 1.7% for the year, driven by 4.5% effective net pricing in Q4 that offset a 2% organic volume decline."
"The impairment charge reduced reported EPS to $6.00, down from $6.95 in the prior year, while core EPS reached $8.14. Free cash flow for the trailing 12 months stood at $7.67 billion."
"PepsiCo's capital-intensive model - owning manufacturing and distribution - delivers scale but thinner margins and higher capex, which ran below 5% of revenue yet still pressured cash conversion."
PepsiCo reported full-year net revenue of $93.9 billion, a 2.3% increase, but net income dropped 14% to $8.24 billion due to a significant impairment charge. The fourth quarter showed improvement with revenue of $29.3 billion, up 5.6%, and core earnings rising 11%. Organic revenue growth was driven by effective pricing, despite a 2% decline in volume. International segments performed well, offsetting North American weaknesses. Free cash flow was strong, but nearly all was used for dividends and stock repurchases, highlighting reliance on pricing amid volume challenges.
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]